Taro Pharmaceutical Industries Ltd (TARO)
42.14
-0.05
(-0.12%)
USD |
NYSE |
Apr 19, 10:25
Taro Pharmaceutical Industries Free Cash Flow (Quarterly): -3.553M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.553M |
| September 30, 2023 | 40.51M |
| June 30, 2023 | 0.933M |
| March 31, 2023 | 48.11M |
| December 31, 2022 | 4.97M |
| September 30, 2022 | 18.96M |
| June 30, 2022 | -60.14M |
| March 31, 2022 | -60.82M |
| December 31, 2021 | -195.24M |
| September 30, 2021 | -54.03M |
| June 30, 2021 | 40.07M |
| March 31, 2021 | 48.23M |
| December 31, 2020 | 37.56M |
| September 30, 2020 | -116.09M |
| June 30, 2020 | 58.91M |
| March 31, 2020 | 41.55M |
| December 31, 2019 | 91.93M |
| September 30, 2019 | 35.10M |
| June 30, 2019 | 74.60M |
| March 31, 2019 | 50.09M |
| December 31, 2018 | 98.54M |
| September 30, 2018 | 68.08M |
| June 30, 2018 | 76.32M |
| March 31, 2018 | 87.71M |
| December 31, 2017 | 81.11M |
| Date | Value |
|---|---|
| September 30, 2017 | 59.28M |
| June 30, 2017 | 66.06M |
| March 31, 2017 | 107.63M |
| December 31, 2016 | 120.66M |
| September 30, 2016 | 126.65M |
| June 30, 2016 | 46.77M |
| March 31, 2016 | 149.56M |
| December 31, 2015 | 104.00M |
| September 30, 2015 | 56.61M |
| June 30, 2015 | 65.86M |
| March 31, 2015 | 207.81M |
| December 31, 2014 | 93.19M |
| September 30, 2014 | 55.88M |
| June 30, 2014 | 29.75M |
| March 31, 2014 | 79.17M |
| December 31, 2013 | 99.73M |
| September 30, 2013 | 92.42M |
| June 30, 2013 | 60.51M |
| March 31, 2013 | 72.26M |
| December 31, 2012 | 87.90M |
| September 30, 2012 | 60.84M |
| June 30, 2012 | 17.40M |
| March 31, 2012 | |
| December 31, 2011 | 58.92M |
| September 30, 2011 | 60.73M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-195.24M
Minimum
Dec 2021
91.93M
Maximum
Dec 2019
2.715M
Average
35.10M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| InspireMD Inc | -4.392M |
| Ayala Pharmaceuticals Inc | -- |
| BiomX Inc | -6.249M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -3.77M |